These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 32723832

  • 1. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
    Davies JC, Midgley A, Carlsson E, Donohue S, Bruce IN, Beresford MW, Hedrich CM.
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
    [Abstract] [Full Text] [Related]

  • 2. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
    Donohue SJ, Midgley A, Davies JC, Wright RD, Bruce I, Beresford MW, Hedrich CM, MRC MASTERPLANS Consortium, UK jSLE Cohort Study and Repository.
    Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
    [Abstract] [Full Text] [Related]

  • 3. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H, Lood C, Gullstrand B, Jönsen A, Ivars F, Leanderson T, Bengtsson AA.
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [Abstract] [Full Text] [Related]

  • 4. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H, Lood C, Gullstrand B, Jönsen A, Nived O, Sturfelt G, Truedsson L, Ivars F, Leanderson T, Bengtsson AA.
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [Abstract] [Full Text] [Related]

  • 5. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL, Fall N, Thornton S, Witte D, Bennett MR, Appenzeller S, Klein-Gitelman MS, Grom AA, Brunner HI.
    Arthritis Res Ther; 2017 Oct 24; 19(1):242. PubMed ID: 29065913
    [Abstract] [Full Text] [Related]

  • 6. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
    Wakiya R, Kameda T, Ueeda K, Nakashima S, Shimada H, Mansour MF, Kato M, Miyagi T, Miyatake N, Kadowaki N, Dobashi H.
    Lupus; 2019 Jun 24; 28(7):826-833. PubMed ID: 31068068
    [Abstract] [Full Text] [Related]

  • 7. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
    Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.
    Arthritis Rheumatol; 2019 Mar 24; 71(3):451-459. PubMed ID: 30225949
    [Abstract] [Full Text] [Related]

  • 8. Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.
    Walscheid K, Heiligenhaus A, Holzinger D, Roth J, Heinz C, Tappeiner C, Kasper M, Foell D.
    Invest Ophthalmol Vis Sci; 2015 Dec 24; 56(13):7653-60. PubMed ID: 26624497
    [Abstract] [Full Text] [Related]

  • 9. A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
    Davies JC, Carlsson E, Midgley A, Smith EMD, Bruce IN, Beresford MW, Hedrich CM, BILAG-BR and MRC MASTERPLANS Consortia.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3747-3759. PubMed ID: 33313921
    [Abstract] [Full Text] [Related]

  • 10. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
    Soyfoo MS, Roth J, Vogl T, Pochet R, Decaux G.
    J Rheumatol; 2009 Oct 02; 36(10):2190-4. PubMed ID: 19755614
    [Abstract] [Full Text] [Related]

  • 11. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May 02; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 12. Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.
    Šumová B, Cerezo LA, Szczuková L, Nekvindová L, Uher M, Hulejová H, Moravcová R, Grigorian M, Pavelka K, Vencovský J, Šenolt L, Závada J.
    Rheumatol Int; 2019 Mar 02; 39(3):469-478. PubMed ID: 30392117
    [Abstract] [Full Text] [Related]

  • 13. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH, Brun JG, Hordvik M, Eidsheim M, Jonsson R, Halse AK.
    Scand J Rheumatol; 2016 Jul 02; 45(4):274-81. PubMed ID: 26767827
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
    Thames BE, Barr JW, Suchodolski JS, Steiner JM, Heilmann RM.
    J Vet Diagn Invest; 2019 Jul 02; 31(4):645-651. PubMed ID: 31170888
    [Abstract] [Full Text] [Related]

  • 15. A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
    Yu Y, Shi H, Wang Y, Yu Y, Chen R.
    ESC Heart Fail; 2024 Feb 02; 11(1):503-512. PubMed ID: 38083998
    [Abstract] [Full Text] [Related]

  • 16. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
    Puapatanakul P, Chansritrakul S, Susantitaphong P, Ueaphongsukkit T, Eiam-Ong S, Praditpornsilpa K, Kittanamongkolchai W, Avihingsanon Y.
    Int J Mol Sci; 2019 Oct 08; 20(19):. PubMed ID: 31597273
    [Abstract] [Full Text] [Related]

  • 17. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F, Shaharir SS, Abdul Wahab A, Mustafar R, Abdul Gafor AH, Mohamed Said MS, Rajalingham S, Shah SA.
    Int J Rheum Dis; 2019 Aug 08; 22(8):1419-1426. PubMed ID: 31179646
    [Abstract] [Full Text] [Related]

  • 18. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
    Kim JW, Jung JY, Lee SW, Baek WY, Kim HA, Suh CH.
    Front Immunol; 2022 Aug 08; 13():886209. PubMed ID: 35529863
    [Abstract] [Full Text] [Related]

  • 19. S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs.
    Roszkowski L, Jaszczyk B, Plebańczyk M, Ciechomska M.
    Int J Mol Sci; 2022 Dec 31; 24(1):. PubMed ID: 36614150
    [Abstract] [Full Text] [Related]

  • 20. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
    Xue J, Yang J, Yang L, Zhou S, Ji C, Wang X, Yu N, Liu X, Chi S.
    J Immunol Res; 2017 Dec 31; 2017():6861575. PubMed ID: 28373995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.